More from Curaleaf

Sapphire Clinics is now Curaleaf Clinic. Click here to see what has changed and how it affects you.

Accessibility Statement

We are committed to making this website accessible, in accordance with the Web Content Accessibility Guidelines (WCAG) version 2.1 AA standard. However, some areas are currently not fully compliant for the reasons listed below.

If you need information on this website in a different format, like accessible PDF, large print, easy read, audio recording or Braille, please contact us.

We’ll consider your request and get back to you in 10 working days.

Accessing this site with assistive technology

For people requiring assistive technology and help with browser functionality, AbilityNet provide “My Computer, My Way”. It can help customise and enhance your digital experience to suit your unique needs and preferences.

To learn how to effectively translate to other languages, Kinsta provide a step-by-step guide for different browsers and devices.

All of our website content is made available to browser-specific translation services, such as Google Translate.

Non-Accessible Content

HTML issues:

  • Headings are not nested properly, which affects how users navigate through assistive technologies. This violates WCAG 2.1 success criterion 1.3.1 (Info and Relationships).
  • Missing alternative text on some images, making the images inaccessible to screen readers. This is non-compliant with WCAG 2.1 success criterion 1.1.1 (Non-text Content).

Forms:

  • Some form controls lack associated labels, making them difficult to understand and operate via assistive technologies. This violates WCAG 2.1 success criterion 1.3.1 (Info and Relationships).
  • Some errors are not identified and described to the user in text alone, violating WCAG 2.1 success criterion 3.3.1 (Error Identification).

Links:

  • Some links open new windows without warning, which can be disorienting for users, especially those using screen readers. This goes against WCAG 2.1 success criterion 3.2.1 (On Focus).

Multimedia:

  • Missing transcripts for audio-only content, which is non-compliant with WCAG 2.1 success criterion 1.2.1 (Audio-only and Video-only (Prerecorded)).

Contrast:

  • Text contrast is insufficient in some parts of the website, making it hard to read for users with low vision or color deficiencies. This violates WCAG 2.1 success criterion 1.4.3 (Contrast (Minimum)).

Keyboard Accessibility:

  • Some elements are not focusable or are missing focus indicators, making it hard to navigate with a keyboard. This goes against WCAG 2.1 success criterion 2.4.7 (Focus Visible).

Translation

To translate our website into another language, you can use the Google Translate toolbar, which is available here: https://www-sapphireclinics-com.translate.goog/?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp

Once you have clicked the link, you will be taken to our home page, which will include a translation toolbar, allowing you to switch between many different languages.

What We’re Doing to Improve Accessibility

We are making sure that accessibility issues highlighted in this statement are being prioritised and fixed. Measures include:

  • Reviewing form controls with the agency responsible for out website
  • Correcting JavaScript errors with the agency responsible for out website
  • Reviewing multimedia files to add transcripts of critical audio-only content
  • Reviewing HTML compliance, including viewport and keyboard accessibility with the agency responsible for out website

Reporting accessibility problems with this website

We’re always looking to improve the accessibility of this website. If you find any problems not listed on this page or think we’re not meeting accessibility requirements, please contact us to report this.

Preparation of this Statement

This statement was generated in August 2023.

The website was tested by Unit Digital who performed a test against all level AA success criteria for WCAG 2.1.

The accessibility of this site will be reviewed on a regular basis, with a full site audit scheduled for February 2024. We will continue to update this statement with relevant changes.